Hammond J M, Potgieter P D
Respiratory Intensive Care Unit, University of Cape Town, South Africa.
Crit Care Med. 1995 Apr;23(4):637-45. doi: 10.1097/00003246-199504000-00010.
To determine whether selective decontamination of the digestive tract exerts any long-term effects on antimicrobial resistance patterns.
A surveillance and interventional study comparing the antimicrobial sensitivity patterns of clinically important bacterial isolates the year before a 2-yr, double-blind, randomized, controlled study of selective decontamination of the digestive tract, and for the year thereafter when no use of the regimen was made.
A ten-bed respiratory intensive care unit (ICU) in a 1,200-bed teaching hospital.
All 1,528 patients admitted to the ICU over the 4-yr study period were included. There were 406 patients admitted in the year before the study of decontamination of the digestive tract (65% medical, 23% surgical, and 12% trauma), of whom 76% required mechanical ventilation. There were 719 patients admitted during the 2-yr study of selective decontamination (55% medical, 28% surgical, and 17% trauma), of whom 79.6% required mechanical ventilation. There were 403 patients admitted in the subsequent year (61% medical, 25% surgical, and 14% trauma), of whom 76.9% required mechanical ventilation.
We performed daily clinical monitoring to detect nosocomial infection, with microbiological investigation when clinically indicated, as well as twice-weekly routine microbiological surveillance sampling. Antimicrobial susceptibility testing using standard laboratory methods was also performed. Selective decontamination of the digestive tract included parenteral cefotaxime and oral and enteral polymyxin E, amphotericin B, and tobramycin.
The occurrence rate of nosocomial infection was 20.6%, 16.6%, and 25.3%, respectively, in the three study periods. In the year after selective decontamination, there was an increase in the occurrence rate of infection (p = .005), with an-associated increase in infections caused by the Enterobacteriaceae, while a reduction in the level of resistance to the third-generation cephalosporins were found (p = .07). There was a progressive increase in the occurrence rate of infections caused by Acinetobacter species (p = .05). Only 11 infections over the 4 yrs were caused by Enterococcus species. Staphylococcal infections were uncommon (5.7% of admissions), and the level of methicillin resistance did not change. No increase in aminoglycoside resistance occurred.
No long-term effects on antimicrobial resistance or the spectrum of nosocomial pathogens could be attributed to the use of selective decontamination of the digestive tract over a 2-yr period in a respiratory ICU admitting all categories of patients.
确定消化道选择性去污是否对抗菌药物耐药模式产生任何长期影响。
一项监测与干预性研究,比较在一项为期2年的消化道选择性去污双盲、随机、对照研究前一年以及此后未使用该方案的那一年中,临床重要细菌分离株的抗菌药物敏感性模式。
一家拥有1200张床位的教学医院中的一个设有10张床位的呼吸重症监护病房(ICU)。
纳入了4年研究期间入住该ICU的所有1528例患者。在消化道去污研究前一年有406例患者入院(内科患者占65%,外科患者占23%,创伤患者占12%),其中76%需要机械通气。在选择性去污的2年研究期间有719例患者入院(内科患者占55%,外科患者占28%,创伤患者占17%),其中79.6%需要机械通气。在随后一年有403例患者入院(内科患者占61%,外科患者占25%,创伤患者占14%),其中76.9%需要机械通气。
我们进行每日临床监测以检测医院感染,临床有指征时进行微生物学调查,以及每周两次的常规微生物学监测采样。还使用标准实验室方法进行抗菌药物敏感性测试。消化道选择性去污包括静脉注射头孢噻肟以及口服和肠内给予多粘菌素E、两性霉素B和妥布霉素。
在三个研究期间,医院感染发生率分别为20.6%、16.6%和25.3%。在选择性去污后的那一年,感染发生率有所增加(p = 0.005),肠杆菌科引起的感染相关增加,同时发现对第三代头孢菌素的耐药水平有所降低(p = 0.07)。不动杆菌属引起的感染发生率逐渐增加(p = 0.05)。4年中仅11例感染由肠球菌属引起。葡萄球菌感染不常见(占入院患者的5.7%),耐甲氧西林水平未发生变化。氨基糖苷类耐药未增加。
在收治各类患者的呼吸ICU中,为期2年的消化道选择性去污使用并未对耐药性或医院病原体谱产生长期影响。